SC 13G Filing

Company

Milestone Pharmaceuticals Inc.

Filed

October 31, 2022

Accession Number

0001319244-22-000176

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →